Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression

Hypertension

Volumn 68, Issue 1, 2016, Pages 114-122

  Wang, Huan ^a   Hou, Lei ^b   Kwak, Dongmin ^a   Fassett, John ^a   Xu, Xin ^a   Chen, Angela ^a   Chen, Wei ^a   Blazar, Bruce R ^a   Xu, Yawei ^b   Hall, Jennifer L ^a   Ge, Jun Bo ^b   Bache, Robert J ^a   Chen, Yingjie ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b TONGJI UNIVERSITY   (China)

Author keywords

fibrosis; heart; heart failure; inflammation; lung; regulatory T cell

Indexed keywords

ATRIAL NATRIURETIC FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 MONOCLONAL ANTIBODY JES6 1; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN HEAVY CHAIN BETA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIGEN ANTIBODY COMPLEX; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CARDITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; LEUKOCYTE; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MACROPHAGE; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANALYSIS OF VARIANCE; ANIMAL; ANTIGEN ANTIBODY COMPLEX; BAGG ALBINO MOUSE; DISEASE MODEL; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; IMMUNOLOGY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHARMACOLOGY; RANDOMIZATION; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEART FAILURE; INTERLEUKIN-2; MALE; MICE; MICE, INBRED BALB C; PNEUMONIA; RANDOM ALLOCATION; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84966447566     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07084     Document Type: Article

References (24)

1. Bursi F, McNallan SM, Redfield MM, Nkomo VT, Lam CS, Weston SA, Jiang R, Roger VL. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol. 2012;59:222-231. doi: 10.1016/j. jacc.2011.06.076.
2. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013;62(25 suppl):D100-D108. doi: 10.1016/j. jacc.2013.10.033.
3. Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 2015;15:117-129. doi: 10.1038/nri3800.
4. El-Menyar AA. Cytokines and myocardial dysfunction: state of the art. J Card Fail. 2008;14:61-74. doi: 10.1016/j.cardfail.2007.09.006.
5. Nevers T, Salvador AM, Grodecki-Pena A, Knapp A, Velázquez F, Aronovitz M, Kapur NK, Karas RH, Blanton RM, Alcaide P. Left ventricular T-cell recruitment contributes to the pathogenesis of heart failure. Circ Heart Fail. 2015;8:776-787. doi: 10.1161/CIRCHEARTFAILURE.115.002225.
6. Laroumanie F, Douin-Echinard V, Pozzo J, Lairez O, Tortosa F, Vinel C, Delage C, Calise D, Dutaur M, Parini A, Pizzinat N. CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation. 2014;129:2111-2124. doi: 10.1161/CIRCULATIONAHA.113.007101.
7. Chen Y, Guo H, Xu D, Xu X, Wang H, Hu X, Lu Z, Kwak D, Xu Y, Gunther R, Huo Y, Weir EK. Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension. 2012;59:1170-1178. doi: 10.1161/HYPERTENSIONAHA.111.186072.
8. Haribhai D, Williams JB, Jia S, et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity. 2011;35:109-122. doi: 10.1016/j.immuni.2011.03.029.
9. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med. 2009;206:751-760. doi: 10.1084/jem.20082824.
10. Dinh TN, Kyaw TS, Kanellakis P, To K, Tipping P, Toh BH, Bobik A, Agrotis A. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation. 2012;126:1256-1266. doi: 10.1161/CIRCULATIONAHA.112.099044.
11. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6:1142-1151. doi: 10.1038/ni1263.
12. Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12:180-190. doi: 10.1038/nri3156.
13. Singer BD, King LS, D'Alessio FR. Regulatory T cells as immunotherapy. Front Immunol. 2014;5:46. doi: 10.3389/fimmu.2014.00046.
14. Wang H, Xu X, Fassett J, Kwak D, Liu X, Hu X, Falls TJ, Bell JC, Li H, Bitterman P, Bache RJ, Chen Y. Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failure. Circulation. 2014;129:1397-1406. doi: 10.1161/CIRCULATIONAHA.113.002209.
15. Bluestone JA, Buckner JH, Fitch M, et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med. 2015;7:315ra189. doi: 10.1126/scitranslmed.aad4134.
16. Edozie FC, Nova-Lamperti EA, Povoleri GA, Scottà C, John S, Lombardi G, Afzali B. Regulatory T-cell therapy in the induction of transplant tolerance: the issue of subpopulations. Transplantation. 2014;98:370-379. doi: 10.1097/TP.0000000000000243.
17. Sharir R, Semo J, Shimoni S, Ben-Mordechai T, Landa-Rouben N, Maysel-Auslender S, Shaish A, Entin-Meer M, Keren G, George J. Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling. PLoS One. 2014;9:e113653. doi: 10.1371/journal. pone.0113653.
18. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med. 2006;12:178-180. doi: 10.1038/nm1343.
19. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191-197. doi: 10.1038/ni1428.
20. Weirather J, Hofmann UD, Beyersdorf N, Ramos GC, Vogel B, Frey A, Ertl G, Kerkau T, Frantz S. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. 2014;115:55-67. doi: 10.1161/CIRCRESAHA.115.303895.
21. Saxena A, Dobaczewski M, Rai V, Haque Z, Chen W, Li N, Frangogiannis NG. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol. 2014;307:H1233-H1242. doi: 10.1152/ajpheart.00328.2014.
22. Sakaguchi S. Immunology: Conditional stability of T cells. Nature. 2010;468:41-42. doi: 10.1038/468041a.
23. Pereda D, García-Alvarez A, Sánchez-Quintana D, Nuño M, Fernández-Friera L, Fernández-Jiménez R, García-Ruíz JM, Sandoval E, Aguero J, Castellá M, Hajjar RJ, Fuster V, Ibáñez B. Swine model of chronic postcapillary pulmonary hypertension with right ventricular remodeling: long-term characterization by cardiac catheterization, magnetic resonance, and pathology. J Cardiovasc Transl Res. 2014;7:494-506. doi: 10.1007/s12265-014-9564-6.
24. Wagenvoort CA. Lung biopsy findings in secondary pulmonary hypertension. Heart Lung. 1986;15:429-450.